There is no significant difference in the expression of FMNL3 in the normal tissues and cancer tissue, while we can find only that stage 1 and stage 2 have the difference, which could not give the direct evidence to prove the FMNL3 has effect on the different stages of the breast cancer (Figure 2(c)). This evidence concerns the gene FMNL3 and breast cancer.